Global Identification of Co-Translational Interaction Networks by Selective Ribosome Profiling
October 7th, 2021
2.4K views
Co-translational interactions play a crucial role in nascent-chain modifications, targeting, folding, and assembly pathways. Here, we describe Selective Ribosome Profiling, a method for in vivo, direct analysis of these interactions in the model eukaryote Saccharomyces cerevisiae.
Overview
This study explores the crucial role of co-translational interactions in nascent-chain modifications, targeting, folding, and assembly pathways using selective ribosome profiling. The model organism employed is the eukaryote Saccharomyces cerevisiae.
Key Study Components
Research Area
- Co-translational interactions
- Protein targeting and folding
- Ribosome profiling
Background
- Nascent-chain modifications are vital for protein functionality.
- Understanding these processes can illuminate disease mechanisms.
- Selective ribosome profiling uniquely captures these interactions in vivo.
Methods Used
- Selective ribosome profiling
- Saccharomyces cerevisiae
- RNA extraction, western blotting, deep sequencing
Main Results
- Identified co-translational interactions and binding with ribosome-associated chaperones.
- Demonstrated ribosome occupancy along open reading frames.
- Established the method's validity through various assays.
Conclusions
- The study demonstrates the importance of co-translational interactions for maintaining a functional proteome.
- This approach is relevant for understanding protein synthesis and associated diseases.
Frequently Asked Questions
What is selective ribosome profiling?
Selective ribosome profiling is a method for direct, in vivo analysis of ribosome interactions during protein translation.
Why is Saccharomyces cerevisiae used as a model organism?
It serves as a well-studied eukaryotic model that simplifies the analysis of complex cellular processes.
How does this study contribute to our understanding of diseases?
By elucidating co-translational interactions, this research provides insights into the mechanisms behind protein folding and associated diseases.
What technologies are utilized in this research?
The study employs techniques including selective ribosome profiling, RNA extraction, and deep sequencing for analysis.
What are the implications of co-translational interactions?
These interactions are crucial for ensuring the proper targeting and folding of proteins, impacting their functional roles.
What experimental approaches were taken?
The researchers used immuno-purification and western blot validation, among other methods, to analyze the interactions.
Executive Industry Relevance
Selective ribosome profiling enables direct, in vivo mapping of co-translational interaction networks, providing unprecedented insight into how nascent polypeptides engage with chaperones and assembly factors. This capability addresses a critical gap in understanding protein biogenesis, folding, and complex assembly at the molecular level. The method supports predictive confidence in target validation and mechanistic de-risking for early-stage biopharma discovery pipelines.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables interrogation of co-translational protein-protein interactions during synthesis in living cells.
- Supports mechanistic de-risking by revealing when and where chaperones and assembly factors engage nascent chains.
- Facilitates functional target validation by mapping interaction timing and specificity at near-codon resolution.
- Provides actionable data for triaging targets based on folding and assembly dependencies.
Screening & Assay Development
- Prepares validated biological systems for downstream screening of modulators affecting co-translational processes.
- Delivers quantitative, reproducible ribosome occupancy and interaction profiles for assay standardization.
- Enables high-content screening readiness by linking molecular interactions to translational status.
- Supports platform reuse for diverse protein targets and interaction partners.
Translational & Preclinical Research
- Aligns mechanistic findings with disease-relevant pathways involving protein misfolding or assembly defects.
- Provides continuity from discovery to preclinical validation by tracking interaction networks across conditions.
- Informs risk-adjusted advancement decisions for targets with complex biogenesis requirements.
- Enhances predictive de-risking for therapeutic strategies targeting protein homeostasis.
Pipeline & Workflow Integration
Selective ribosome profiling integrates at the interface of early discovery and lead identification, bridging molecular mechanism elucidation with actionable screening outputs.
- Discovery Biology: Supports hypothesis testing on co-translational engagement of chaperones and assembly factors.
- Screening: Provides reproducible, quantitative readouts of ribosome-associated interactions for assay development.
- Analytics: Delivers high-resolution mapping of interaction sites and occupancy along coding sequences.
- Translational Research: Connects mechanistic insights to disease models involving proteostasis or folding pathologies.
- Enterprise Reuse: Establishes a reusable profiling platform for diverse protein targets and cellular contexts.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence in target validation and reduces mechanistic ambiguity in protein biogenesis.
- Operational Value: Standardizes workflows for ribosome profiling and interaction mapping with scalable protocols.
- Strategic Value: Enables better go/no-go decisions by clarifying folding and assembly liabilities early in the pipeline.
- Portfolio Impact: Supports risk-adjusted prioritization of targets based on biogenesis complexity and interaction dependencies.
Implementation Considerations
- Requires expertise in ribosome profiling, affinity purification, and deep sequencing analytics.
- Demands access to high-speed centrifugation, cryogenic lysis, and advanced bioinformatics infrastructure.
- Necessitates rigorous cross-team standardization for reproducibility and data comparability.
- Adaptation across model systems may require optimization of tagging and purification strategies.
- Potential limitations include sensitivity to sample quality and the need for robust controls for non-specific binding.
Biopharma FAQs
Why does null hypothesis testing matter for co-translational interaction mapping?
Null hypothesis testing ensures that observed co-translational interactions are statistically significant and not due to random association, supporting robust target validation and mechanistic clarity in early discovery.
How does independent variable isolation fit selective ribosome profiling workflows?
Isolating variables such as specific tagged proteins or chaperones allows precise attribution of observed interactions to defined molecular events, enhancing the interpretability and predictive value of the profiling data.
What do quantitative ribosome occupancy measurements enable in R&D?
Quantitative occupancy data provide high-resolution maps of where and when interactions occur along coding sequences, enabling comparative analysis across conditions and supporting data-driven screening and triage decisions.
Why are replication requirements critical for cross-functional collaboration?
Replication ensures that co-translational interaction profiles are reproducible and reliable, facilitating data sharing and integration across discovery, screening, and translational research teams.
What statistical analysis capabilities are required before implementing selective ribosome profiling?
Robust statistical tools are needed to analyze sequencing data, validate enrichment, and distinguish true interactions from background, ensuring actionable insights for portfolio decision-making.
Chapters in this video
0:04
Introduction
0:49
Cell Collection and Lysis
1:29
Processing the Total RNA Sample
2:24
Processing the Immunopurification Sample
4:34
Results: Analysis of Ribosome-Protected Footprint Isolation, RNA Extraction, cDNA Library Creation, and Co-Translational Interactions
6:19
Conclusion
